Prognostic Factors for Overall Survival in Patients With Hormone Receptor-Positive Advanced Breast Cancer: Analyses From PALOMA-3 - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34037282/
Prognostic factors for OS included endocrine sensitivity, nonvisceral disease, ECOG PS of 0, and no prior chemotherapy for ABC. Exploratory analyses suggest improved OS with palbociclib-fulvestrant versus placebo-fulvestrant in patients...
-
Naveed Saleh, MD, MS – Skipta Team5yrKey Points • In this analysis of the PALOMA-3 trial, researchers identified factors that affect survival outcomes in 521 patients with advanced breast cancer (ABC) who were treated with pablociclib-fulvestrant. They Show More
The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34013318/
1 Department of Surgery, Galway University Hospitals, Galway, Ireland. 2 The Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland. 3 Department of Surgery, The Royal College of...
New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34035435/
ISRCTN34086741 (21/7/2004), NCT00983684 (24/9/2009).
Update Breast Cancer 2021 Part 1 - Prevention and Early Stages - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34035547/
This review summarises not only the latest evidence on prevention, but also the current research on the treatment of early-stage breast cancer patients. Recent years have seen a growing body...
EndoPredict ® in early hormone receptor-positive, HER2-negative breast cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/32436145/
EPclin led to a change in therapy recommendations in one third of the patients. Clinico-pathological parameters such as younger age, smaller tumor size, positive nodal status, intermediate histological grade and...